ImmunoScape’s Andreas Wilm offers a behind the scenes look at the machine learning models we trained for research published in Cell Press’ Cell Reports – which validated ImmunoScape’s platform by accurately predicting T-cell antigen specificity through...
ImmunoScape Uses Machine Learning to Accurately Predict Antigen Specificity Based on T-Cell Phenotypes in New Peer-Reviewed Research ImmunoScape’s platform accelerates the discovery of efficacious TCR-based therapeutics for solid tumors SAN DIEGO, Calif., and...
Florian Schmidt, PhD will be presenting at the upcoming ISMB/ECCB 2023 conference in Lyon. On Thursday, July 27th Florian will describe ImmunoScape’s machine learning capability, which we use to infer antigen specificity. He will present in-vitro validation data,...
Our team is headed to #bio2023 in Boston June 5-8! Our CEO Choon-Peng (Choon) Ng and our Senior Director, Business Development Christopher Alfonso will be on site at the convention this year. If you are interested in meeting with them to learn more about our Deep...
